Board of Directors

Board of Directors

Jennifer Marley

Jennifer Marley

Chair of the Board

A proven marketing leader and strategic advisor with 30 years of experience, Jennifer Marley solves the highest-level, toughest strategic challenges for her clients at the marketing advisory firm, Sklar Wilton & Associates (SW&A). In her 18 years at SW&A, Jennifer has been honoured to act as strategic and insights advisor to some of Canada’s finest companies to collaboratively solve tough business challenges to unlock growth and build stronger brands.

Her vision has been a driving force behind many successful culture, engagement and coaching initiatives at SW&A leading the firm to be named as one of Canada’s Best Workplaces, as well as, an Employee Recommended Workplace in 2017 and 2018.

The blood cancer cause is a personal one for Jennifer. She is a 14-year leukemia survivor and is dedicated volunteer for The Leukemia & Lymphoma Society of Canada.  She is also a keen adventurer who enjoys new challenges including biking, hiking, trekking, and zip-lining in some of the most exotic and beautiful parts of the world.  She is a mother of two, Matt 22 and Kate 20, who she is helping transition through university to adulthood. Her husband Murray enjoys accompanying her on her adventures.

Paul Davis

Paul Davis

Vice Chair of the Board & Chair of the Nominating Committee

Paul Davis was diagnosed with Diffuse Large B Cell Lymphoma with an underlying Follicular Lymphoma in 2011. A former 25 year veteran of the Royal Newfoundland Constabulary and member of the Newfoundland and Labrador legislature, Paul says it was the last thing he ever expected to face. 

Paul wasn’t going to allow a cancer diagnosis to stop him from continuing his active lifestyle. Shortly after finishing his curative chemotherapy treatments in the fall of 2011, he was re-elected to the Newfoundland Labrador House of Assembly and elevated to cabinet. Paul continued his political career while undergoing two years of maintenance treatments and in 2014 became the 12th Premier of Newfoundland and Labrador. 

In the fall of 2018 Paul retired from politics but stepped up his involvement with LLSC. As a lifelong volunteer with a long history of serving with local, regional and national organizations, Paul was delighted to join the LLSC Board of Directors and enjoys being an active volunteer with the local Light The Night organizing committee. 

Paul is particularly passionate when it comes to services and supports to patients and their families and believes in the benefits and value of much needed blood cancer research. 

Paul and his wife Cheryl reside in their home town of Conception Bay South, Newfoundland Labrador
 

Gord McFarlane

Gord McFarlane

Treasurer & Chair of the Audit and Finance Committee

Gord McFarlane is the Managing Director of Corporate Development at FYi Doctors. North America’s largest doctor-owned eye care provider with over 300 locations. Prior to joining FYi he had a 30 year career with Grant Thornton LLP including leadership roles as Managing Partner Alberta, Regional Managing Partner Western Canada, member of the firm’s National Management Committee, National Managing Partner of the firm’s Advisory Services across Canada and a term on the firm’s Partnership Board. Gord is a FCA, FCPA and a Chartered Business Valuator (CBV).

Gord is an audit committee member, past treasurer and board member of the HomeSpace Society, a non-profit organization providing housing for Calgary’s homeless. He is the past chair of the Calgary Philharmonic Orchestra and a former trustee of the Calgary Philharmonic Orchestra Foundation. He has served on and advised numerous Boards of Directors over his career both in the corporate and non-profit sector.

Gord was diagnosed with an aggressive Prolymphocytic Leukemia in 2015 and began treatment immediately, which included a successful stem cell transplant from his donor, his sister.

Dr. Keith Humphries

Dr. Keith Humphries

Secretary & Chair of Medical & Scientific Committee

Dr. Keith Humphries, MD PhD, is a distinguished scientist and Director of the Terry Fox Laboratory of the BC Cancer Agency and Professor in the Division of Hematology of the Department of Medicine at the University of British Columbia. His long-standing research interests are focused on understanding the molecular mechanisms that regulate normal blood stem cell properties and how these are altered in leukemia. Studies in his lab have involved a stellar succession of trainees from Canada and around the world that have stimulated new approaches for expanding normal blood stem cells and provided new insights into the mechanisms of leukemic transformation. His laboratory has also been on the forefront of the use of retroviral and lentiviral - mediated gene transfer to human as well as mouse blood stem cells and has used this technology to develop powerful new models for studying how specific genes contribute to leukemia development. He is an active promoter of translational science and a collaborator on many team projects both nationally and internationally. He has a long track record of research accomplishments supported and contributions to scientific societies and journals. Dr. Humphries has been recognized by numerous prestigious awards including the 2013 Terry Fox Gold Medal and induction as a Fellow of the Royal Society of Canada.

He has been an active member of many international scientific societies. He has served in senior elected executive roles in the International Society of Experimental Hematology, and served as President and then as Editor in Chief of the associations journal, Experimental Hematology. He was a founding member in 1999 of the NCE-funded Stem Cell Network and remains active in the Canadian Stem Cell Network Foundation. He currently serves on the Scientific Advisory Board of the Hemato-Linne Stem Cell Program (centered in Lund, Sweden) and bluebird bio and has previously been an advisor to the hematology research program at Millenium and Systemix. He has previously served as an advisor to the Terry Fox Foundation and currently sits on the Medical-Scientific committee of the Leukemia Lymphoma Society of Canada.  Dr. Humphries has served on numerous review panels both nationally and internationally including serving as member of the Score Committee of the Leukemia and Lymphoma Society (USA), member and chair of the scientific panel for the Leukemia Lymphoma Society of Canada, the hematopoiesis panel of the National Cancer Institute and site visit panels for the Terry Fox Program.

Ted Moroz

Ted Moroz

Past Chair

Ted Moroz has been President of The Beer Store and Brewers' Distributor Limited since September, 2009. In this role he oversees 450 Retail Stores in Ontario, 16 Distribution Centres from British Columbia to Ottawa, and multiple cross-dock facilities throughout Canada, with a total of 7,000+ employees. Ted started his career with The Beer Store (then Brewers Retail Inc.) in 1989, holding various management positions over the years. The Beer Store has been a proud partner of United Food & Commercial Workers (UFCW) Local 12R24 in organizing an annual Returns For Leukemia Bottle Drive since 2006. Ted joined the LLSC National Board in 2010. 

Alex Beraskow

Alex Beraskow

Chair of the Investment Committee

Alex Beraskow is a retired management consultant with a background in information technology and finance.  He started his career with IBM and worked within the IT domain for 4 decades. He has had executive responsibility, including P&L, for 5 consulting firms since 1980.  He founded three consulting companies and sold each of them to international firms.

Since selling his last firm – IT/net – he has transitioned his career to that of corporate governance, working as a corporate director for both Not-For-Profit (NFP), as well as corporate boards.  Currently he is on the Board of Governance at the University of Ottawa.  In past, he has been on the boards of ICCRC, CIRA, Lymphoma Canada, Opera Lyra, and Rideau Club.  His committee work includes finance, investment management, pension, and governance.  Interests include strategic planning, risk management, compensation and all matters related to corporate governance.

 

Frédéric Chevalier

Frédéric Chevalier

Chair of the Cancer Advisory Committee

Frédéric is an expert in business intelligence and knowledge management. He has developed and supported several innovative and pioneering research projects in artificial intelligence and economic data management. Committed to the development of companies and organizations he works with, Frédéric uses a rigorous project management methodology and a Glow to Grow approach which allow him to contribute to the success of complex projects involving private companies and public agencies.

Frédéric was the managing partner of a consulting practice specialized in business intelligence and economic and industrial development for 14 years before he joined the Quebec Cluster of Metal Transformers as Chief Executive Officer.

As a speaker and strategic advisor, Frédéric wrote several industry reports and briefs, participated in parliamentary committees, and organized strategic forums for the development of industry clusters.

In early 2017 Frederic was diagnosed with an aggressive non-Hodgkin's lymphoma stage IV and, thanks to the support of the Canadian medical community, he is now undergoing his maintenance treatment.

 

Rick Lancaster

Rick Lancaster

Chair of the HR & Governance Committee

Rick Lancaster is a retired financial services industry senior executive and former President and CEO of CIBC Life Insurance. Rick served on a not-for-profit board supporting Scouts Canada for 7 years. He was also former chair and director of the Canadian Association of Financial Institutions in Insurance.  Rick has his CPA-CGA designation, an MBA from the University of Toronto and an HBA from the Ivey School of Business, Western University.  Rick is a 6 year survivor of NHL.

Jeffrey Bacha

Jeffrey Bacha

Board Member

Jeffrey Bacha is an experienced senior executive with more than twenty years in the life sciences industry focused in the areas of operations, strategy and finance. His background includes successful public and private company building from both a start-up and turn around perspective; establishing and leading thriving management and technical teams; and raising capital in both the public and private markets.

Currently, Jeffrey is the CEO of Edison Oncology Holding Corp., a company he established to develop and commercialize new therapies in the fight against cancer. Prior to founding Edison Oncology, he led the growth of DelMar Pharmaceuticals, Inc. from its inception in 2010 through its listing on NASDAQ and advancement of its lead product candidate to pivotal Phase 3 clinical trials. In addition to his role at Edison Oncology, Jeffrey serves as an independent director and chair of the Compensation Committee for Sernova Corp., where he has been a member of the Board of Directors since 2008. 

Jeffrey has been recognized as a “Top 40 under 40” executive by Business in Vancouver magazine and is the former Chair of the Greater Vancouver Economic Council. 

Jeffrey is active in his community through volunteerism with the Leukemia & Lymphoma Society’s Team in Training program and as former Chairman of the Board for Covenant House Vancouver.

Rich Bagger

Rich Bagger

Board Member

Rich Bagger served as executive vice president of corporate affairs and market access for Celgene from January 2012 through December 2019, where he oversaw communications, patient advocacy, government relations and policy, market access, global health and corporate responsibility. Before joining Celgene, Bagger was chief of staff for New Jersey governor Chris Christie.

His public service also includes 11 years in the New Jersey senate and assembly, where he was chair of the appropriations committee and majority conference leader. Previously, Bagger worked at Pfizer for more than 16 years in a series of positions of increasing responsibility within the company’s U.S. pharmaceuticals, corporate affairs and worldwide pharmaceuticals divisions. He currently teaches at the Rutgers University Eagleton Institute of Politics and is a Commissioner of the Port Authority of New York and New Jersey.

He received a bachelor’s degree from Princeton University’s School of Public and International Affairs and a law degree from Rutgers University Law School.

Dan Coyle

Dan Coyle

Board Member

Dan Coyle is the Vice President and Eastern Region Manager for Marsh Canada’s Consumer & Commercial Department. Dan is accountable for all aspects of brokering and supporting strategies to position Marsh Canada for accelerated profitable growth in the Eastern Region, while insuring an exceptional customer experience and efficient business interactions with Marsh’s insurers and vendors. He is recognized as an inspirational leader with a high level of enthusiasm and professionalism to take on any challenge. Dan was recently recognized as one of the 2016 Young Guns of insurance by Insurance Business Magazine and Nouveaux leadeurs en assurance 2018 by Le Journal de l’Assurance.

In 2017, Dan’s uncle passed away from AML leaving his wife and two teenage daughters behind. He is actively involved in several community service organizations. Currently, he is the proud member of Montreal’s Light the Night Walk Volunteer Leadership Committee where he was Chair of the Walk in 2016. Dan and his wife are proud to raise two amazing daughters together.

Louis J. DeGennaro

Louis J. DeGennaro

LLS President and Chief Executive Officer

Louis J. DeGennaro, Ph.D., is president and chief executive officer of The Leukemia & Lymphoma Society (LLS), a global leader in the fight against cancer. Dr. DeGennaro leads the mission and operations of this $400 million cancer patient advocacy agency with headquarters in Rye Brook, New York.

Dr. DeGennaro has been a member of the LLS executive leadership team since he joined LLS as chief scientific officer in 2005. He was named LLS chief mission officer in 2009, with responsibility for leadership of all of LLS's mission functions, including research, patient education and support, public policy and advocacy. He was named president and CEO in September 2014.

As the key architect of LLS's cures and access agenda, Dr. DeGennaro conceived and pioneered LLS’s Therapy Acceleration Program® - a venture philanthropy approach to accelerating new treatments to patients through drug discovery and development partnerships with the biotechnology industry. LLS’s foray into venture philanthropy helped redefine the activist role of nonprofits to meet urgent unmet medical needs.  Under Dr. DeGennaro’s leadership LLS launched its groundbreaking precision medicine Beat AML® Master Trial in October 2016, leading the offensive against acute myeloid leukemia, one of the most deadly blood cancers. 

Dr. DeGennaro has devoted his career to saving lives through drug discovery – first in academic research, later directing drug development at several pharmaceutical companies. At LLS he has found the perfect intersection of science and patient care, overseeing the funding of cutting-edge research, supporting patients and engaging in patient advocacy work. In addition to providing leadership and vision for his staff, he is committed to keeping a significant constituency of volunteers motivated and dedicated to the organization.

After receiving his doctorate in biochemistry from the University of California at San Francisco, Dr. DeGennaro did his post-doctoral research at the Yale University School of Medicine.  His previous academic appointments include research group leader, Max Planck Institute in Munich, Germanyand associate professor of neurology and cell biology, University of Massachusetts Medical School.  His previous private sector appointments included Senior Director, Molecular Genetics, Wyeth Pharmaceuticals and Executive Vice President, Synex Pharmaceuticals

Anna Giagkou

Anna Giagkou

Board Member

Anna Giagkou is a senior finance executive with over 15 years of experience in developing strategies, leading teams and driving results in the audience measurement, market research and software development industries.  In her current role as Vice President of Finance for Numeris, (an industry owned, not-for profit organization), she has extensive experience working with the Board of Directors and with the Audit Committee of the organization.  In addition to her passion for finance and media, Anna has served on a not-for-profit board supporting a community day care for six years, three of which were in the role of Treasurer.  Anna holds a CPA, CMA designation.

Derek Johnstone

Derek Johnstone

Board Member

Derek Johnstone is Special Assistant to the National President of the United Food and Commercial Workers Union (UFCW Canada), one of Canada’s largest private-sector unions: representing a quarter of a million workers in more than 600 communities across the country. 

A UFCW member for nearly 25 years, Derek has served the union in various capacities, including local steward, national representative, and regional director. As Special Assistant, Johnstone engages stakeholders as the union’s research, communications, and skills development principal. He also serves as administrator of the union’s strike and lockout resource, the National Defence Fund.

From 2014 to 2019, Derek served as Vice-Chair of the Ontario Prevention Council, where he worked with employers, civil society organizations and academics to develop and advance the province’s health and safety system and provide enhanced protections for vulnerable worker populations.

Like many UFCW Canada members – who have collectively raised more than $43-million for blood cancer research – Derek is an enthusiastic participant in LLSC fundraising initiatives.

Derek is a graduate of Western University, and has completed professional education programs in public relations, board governance and group benefit plans.

Stephanie Mazzei

Stephanie Mazzei

Board Member

Stephanie is a senior pharmaceutical and biotech entrepreneur and consultant with decades of experience advising Global C-Suite Executives about optimal commercialization strategies for game-changing improvements in cancer care. She’s the founder and currently the President of OncoLogic Inc., a boutique strategy, forecasting, research and due diligence consulting firm. Stephanie was also the co-founder of Strategic Answers Inc. where she helped develop and launch a software program to estimate the future prevalence of cancer patients and led business development activities until the company was acquired in 2016. Prior to her start-up and consulting roles she held senior marketing and strategic planning roles at Bristol-Myers Squibb and Eli Lilly and Company. Stephanie is currently a member of the Board of Directors of Scientists in School in addition to serving as an Advisor to the ALS Society of Canada and to the Life Sciences Health Innovation Hub of Springboard Enterprises. Stephanie holds a BSc (Honours) in Life Sciences and a MSc. (Pathology) from Queen’s University (NCIC Scholarship).

Angela C. Onesi

Angela C. Onesi

Board Member

A McGill graduate, Angela C. Onesi has practiced law since the beginning of her career at Fasken Martineau DuMoulin LLP.  She is a partner and Co-Leader of the firm’s Banking and Finance group. Angela advises clients in a wide array of industries on corporate and commercial financing, capital markets, private placements, project development and financing, acquisition financing and leasing.  She structures, negotiates and manages all aspects of these financing transactions, including leading the teams required to close them.  She prides herself on providing strategic, practical and business minded advice to her clients.

A fervent believer in the importance of volunteerism, Angela has been involved in a number of community organizations over the years including as a director of the Foundation of the Women’s Centre of Montreal since 2015.  As a survivor of non-Hodgkin’s lymphoma thanks, in part, to so many giving so much, Angela is committed to contributing to the mission of the LLSC.

Alexander Pritchard

Alexander Pritchard

Board Member

Al has a deep knowledge and passion for international business. Since 2017, Al has been creating and connecting Canadian companies to international sales and business opportunities in his role as an Global Trade Director at Export Development Canada (EDC).  His primary focus has been EDC’s Mining & Metals Connections Financing portfolio with geographic focus in South America and the Middle East. Al works closely with Canadian companies of all sizes to connect them with international opportunities and to develop strategic relationships to enable international growth.

Prior to joining EDC, Al held various positions with Sander Geophysics Ltd (SGL), an airborne contractor the mining and energy exploration sectors. During his time with SGL Al managed projects on all 7 continents and operated remote operations globally. To execute on projects, Al relocated to many parts of the world including: Guatemala, India, Papua New Guinea, Saudi Arabia and more.

In August 2019, Al was diagnosed with Anaplastic Large Cell Lymphoma and underwent chemotherapy. After a successful treatment regime, Al has been in remission since January 2020. Given his recent bought with this disease, Al is eager to give back and help those going through similar experiences and is focused on the ultimate goal of finding a cure for blood cancers.

Al has a passion for global travel, the outdoors and cooking; each of which he enjoys doing best with his young family.

Bart Sichel

Bart Sichel

Board Member

Bart Sichel’s interest and passion for LLS is deeply personal: His son is a leukemia survivor, and in 2005 he lost his father to lymphoma. Sichel was formerly the Chief Marketing Officer at Burlington Stores, where he was instrumental in shaping the strong bond between Burlington, a national off-price retailer, and LLS, a relationship that has generated more than $25 million for blood cancer research and patient services.

Prior to Burlington, Sichel was a principal at McKinsey & Company, where he specialized in marketing and e-commerce for clients in a wide range of industries. It was his work with the firm's social sector office that strengthened his passion for making a difference in nonprofit settings. Sichel received a bachelor's degree in political science and economics from Vassar College and an MBA in marketing from Columbia University.